These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22054125)

  • 1. Lack of association between apolipoprotein C3 gene polymorphisms and risk of coronary heart disease in a Han population in East China.
    Yu J; Huang J; Liang Y; Qin B; He S; Xiao J; Wang H; Zhong R
    Lipids Health Dis; 2011 Nov; 10():200. PubMed ID: 22054125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association between APOC3 promoter region polymorphisms and non-alcoholic fatty liver disease].
    Niu T; Jiang M; Liu H; Jiang X; Lin Z; Zhang M; Wang J; Geng N; Xin Y; Xuan S
    Zhonghua Gan Zang Bing Za Zhi; 2014 May; 22(5):374-9. PubMed ID: 25180874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association between apolipoprotein C3 gene polymorphisms and risk of nonalcoholic fatty liver disease in a Chinese Han population.
    Niu TH; Jiang M; Xin YN; Jiang XJ; Lin ZH; Xuan SY
    World J Gastroenterol; 2014 Apr; 20(13):3655-62. PubMed ID: 24707151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between apolipoprotein C3 Sst I, T-455C, C-482T and C1100T polymorphisms and risk of coronary heart disease.
    Lin B; Huang Y; Zhang M; Wang J; Wu Y
    BMJ Open; 2014 Jan; 4(1):e004156. PubMed ID: 24430880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Sst I polymorphism in apolipoprotein C3 gene with hypertriglyceridaemia in coronary atherosclerotic heart disease and type II diabetes mellitus in Chinese population.
    Liu HK; Li XF; Zhang SZ; Ren Y; Yong-Xin ; Liu YQ; Wang CT; Chen X; Hu YM; Zhang L
    Yi Chuan Xue Bao; 2005 Jan; 32(1):11-8. PubMed ID: 15715433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels.
    Yin RX; Li YY; Lai CQ
    Lipids Health Dis; 2011 Aug; 10():140. PubMed ID: 21854571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein C3 genetic polymorphisms are associated with lipids and coronary artery disease in a Chinese population.
    Cui F; Li K; Li Y; Zhang X; An C
    Lipids Health Dis; 2014 Nov; 13():170. PubMed ID: 25380998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome.
    Miller M; Rhyne J; Chen H; Beach V; Ericson R; Luthra K; Dwivedi M; Misra A
    Arch Med Res; 2007 May; 38(4):444-51. PubMed ID: 17416293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
    Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
    Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
    Niculescu LS; Vlădică M; Sima AV
    Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of the apolipoprotein E epsilon3/epsilon2/epsilon4, the cholesteryl ester transfer protein TaqIB, and the apolipoprotein C3 -482 C>T polymorphisms on their association with coronary artery disease.
    Muendlein A; Saely CH; Marte T; Schmid F; Koch L; Rein P; Langer P; Aczel S; Drexel H
    Atherosclerosis; 2008 Jul; 199(1):179-86. PubMed ID: 18289550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein C3 gene polymorphisms in Southern Indian patients with nonalcoholic fatty liver disease.
    Puppala J; Bhrugumalla S; Kumar A; Siddapuram SP; Viswa PD; Kondawar M; Akka J; Munshi A
    Indian J Gastroenterol; 2014 Nov; 33(6):524-9. PubMed ID: 25319715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver.
    Valenti L; Nobili V; Al-Serri A; Rametta R; Leathart JB; Zappa MA; Dongiovanni P; Fracanzani AL; Alterio A; Roviaro G; Daly AK; Fargion S; Day CP
    J Hepatol; 2011 Dec; 55(6):1409-14. PubMed ID: 21777557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between plasma lipid parameters and APOC3 genotypes in Brazilian subjects: effect of gender, smoking and APOE genotypes.
    Fiegenbaum M; de Andrade FM; Hutz MH
    Clin Chim Acta; 2007 May; 380(1-2):175-81. PubMed ID: 17367769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Apolipoprotein C-III Gene Polymorphisms and Coronary Heart Disease: A Meta-analysis.
    Zhang JZ; Xie X; Ma YT; Zheng YY; Yang YN; Li XM; Fu ZY; Dai CF; Zhang MM; Yin GT; Liu F; Chen BD; Gai MT
    Aging Dis; 2016 Jan; 7(1):36-44. PubMed ID: 26816662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of polymorphisms in the apolipoprotein APOA1-C3-A5 gene cluster with acute coronary syndrome.
    Ding Y; Zhu MA; Wang ZX; Zhu J; Feng JB; Li DS
    J Biomed Biotechnol; 2012; 2012():509420. PubMed ID: 22675253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons.
    van Hoek M; van Herpt TW; Dehghan A; Hofman A; Lieverse AG; van Duijn CM; Witteman JC; Sijbrands EJ
    Diabetologia; 2011 Jun; 54(6):1360-7. PubMed ID: 21373834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans.
    Sentinelli F; Romeo S; Maglio C; Incani M; Burza MA; Scano F; Coccia F; Cossu E; Leonetti F; Baroni MG
    Lipids Health Dis; 2011 Jun; 10():93. PubMed ID: 21663607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.
    Petersen KF; Dufour S; Hariri A; Nelson-Williams C; Foo JN; Zhang XM; Dziura J; Lifton RP; Shulman GI
    N Engl J Med; 2010 Mar; 362(12):1082-9. PubMed ID: 20335584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
    Hallman DM; Srinivasan SR; Chen W; Boerwinkle E; Berenson GS
    Metabolism; 2006 Dec; 55(12):1574-81. PubMed ID: 17142127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.